LEADERSHIP COUNCIL
Stony Brook University
Stony Brook University has established itself as one of America’s most dynamic public universities, a center of academic excellence and an essential part of the region’s economy. Now, transformed by a historic $150 million gift from Jim and Marilyn Simons and the Simons Foundation — among the top 10 gifts to public higher education in America — Stony Brook is poised to accelerate its trajectory of excellence.
U.S.News & World Report ranks Stony Brook among the top 100 universities in the nation, and the Times Higher Education World University Rankings places us among the top 1 percent of all the universities in the world. A member of the prestigious, invitation-only Association of American Universities, Stony Brook is one of the 61 leading research institutions in North America and the co-manager of Brookhaven National Laboratory. Nobel laureates, Guggenheim fellows and MacArthur grant winners teach on our campus, making it a magnet for outstanding students. The University offers more than 200 undergraduate and 140 graduate programs and has 24,100 students.
Stony Brook’s 1,040-acre campus on Long Island’s North Shore encompasses not only the main academic areas of the University, but also Stony Brook Medicine, which includes the five health sciences schools, Stony Brook University Hospital, Stony Brook Long Island Children’s Hospital, the Long Island State Veterans Home, and our major healthcare centers, programs and clinics. The University’s reach also extends to a Research and Development Park, four business incubators, Stony Brook Manhattan and our Southampton campus on Long Island’s East End.
www.stonybrook.edu | Facebook | Twitter: @stonybrooku
NYSTAR
Empire State Development’s Division of Science, Technology and Innovation (NYSTAR) mission is to accelerate the growth of New York State’s high-tech economy. NYSTAR’s programs are designed to enable new and existing businesses to become more competitive through the use of innovative technologies, and emphasize the importance of working with industry to leverage the state’s technology strengths to produce new products and, therein, new and expanded jobs in the state.
Through funded programs which support world-class technology research at colleges and universities, NYSTAR works to promote a robust network of industry-university partnerships throughout the state. Its support of Regional Technology Development Centers provides direct technology assistance to small and medium size manufacturers and other businesses.
NYSTAR’s responsibilities include the administration and oversight of the following state programs:Centers of Excellence, Centers for Advanced Technology, Regional Technology Development Centers, and High Performance Computing. NYSTAR and its partners are proud to be contributing to the growth of the Innovation Economy in New York State.
esd.ny.gov/nystar/
PLATINUM
AstraZeneca
AstraZeneca is global innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare. We focus primarily on cancer, cardiovascular/metabolic disease and respiratory, inflammatory and autoimmune disease. Alongside this, we remain active in infection and neuroscience with targeted investments in opportunities and collaborations. Everything we do at AstraZeneca is driven by our commitment to improving the lives of patients. Whether that’s working to reach more people with our medicines, or applying our science skills to developing the next generation of treatments, or collaborating with others in the fight against disease, everything centers on understanding and meeting the needs of people facing serious health challenges. Science and patients are at the heart of everything we do, and our skills and resources are concentrated on those therapy areas where we believe we can make the most difference. We conduct our research across 3 continents and we invest over $4 billion each year in the discovery and development of the next generation of innovative medicines targeting unmet needs. We work in over 100 countries and our medicines are used by millions of patients worldwide. We manufacture in 16 countries and are committed to ensuring a reliable supply of medicines where and when they are needed. Our sales in 2012 totaled around $28 billion.
www.astrazeneca.com/partnering
Covington & Burling LLP
Covington & Burling LLP is a leading law firm with one of the largest and most comprehensive life sciences-focused practices in the world. We represent both emerging and established biotechnology and pharmaceutical companies in the US, Europe and Asia, as well as in other major and emerging markets. Covington’s multi-disciplinary and multi-jurisdictional approach combines our US and cross-border corporate transactional practice–including licensing and strategic collaborations, M&A, venture capital financings, securities, finance and royalty monetization transactions–with our capabilities in regulatory, reimbursement, IP, litigation, product liability, government affairs, antitrust and trade. Our regulatory practice includes two former Chief Counsels of the FDA and covers every facet of this industry practice in the US and Europe. Our reimbursement practice includes a former senior agency official and covers advice on reimbursement strategy and process, as well as Medicare and Medicaid issues. For more information, please visit: www.cov.com.
www.cov.com | Twitter: @CovingtonLLP
GOLD
EisnerAmper LLP
EisnerAmper LLP is a leading full-service advisory and accounting firm. We provide audit, accounting, and tax services, as well as IPO, corporate finance, internal audit and risk management, litigation services, consulting, private business services, employee benefit plan audits, forensic accounting, and other professional advisory services to a broad range of clients, including pharmaceutical, biotechnology, and medical device companies. We work with start-ups, high net worth individuals, family offices, closely held businesses, and Fortune 500 companies. EisnerAmper is PCAOB-registered and serves more than 150 public companies and over 1,300 financial services entities and portfolio companies. As companies grow, we help them reach their goals every step of the way. With offices in New York, New Jersey, Philadelphia, California, Connecticut, Ireland and the Cayman Islands, and as an independent member of PKF International, EisnerAmper serves clients worldwide. Contact Steve Kreit (steven.kreit@eisneramper.com) for more information.
www.eisneramper.com|LinkedIn |Facebook | Twitter:@EisnerAmper
Empire State Development
Empire State Development (ESD) is New York State’s lead economic development agency. We offer targeted economic development programs, such as the START-UP NY initiative, Innovate NY and the Excelsior Jobs Program.
Under START-UP NY qualifying businesses can locate in a tax free zone and operate tax free for 10 years. The Innovate NY Fund is a seed stage business equity fund with up to $45 million to support innovation, job creation, and high growth entrepreneurship throughout the state. Strategic businesses that create jobs or make significant capital investments can apply for discretionary refundable tax credits through the Excelsior Jobs Program.
Businesses can take advantage of our solid economic development experience to build a new facility, relocate, expand their operations and work force, and enter new markets and international arenas. New York is everything you want and deserve in a business partner. And that’s why so many companies are coming to and expanding in New York State.
www.esd.ny.gov | LinkedIn | Facebook| Twitter: @EmpireStateDev
Kenyon & Kenyon LLP
Kenyon & Kenyon LLP is a leading intellectual property law firm whose sophisticated and business-oriented approach helps clients succeed with their intellectual property strategies. Our global clients, many of whom are worldwide industry leaders, rely on us for their high-stakes litigation, prosecution, licensing, and counseling needs. Founded in 1879, the firm has offices in New York; Palo Alto; and Washington, DC.
www.kenyon.com | Blogs | Twitter: @KenyonLaw
Merck
With a steady focus on innovation and sound science, Merck has worked for more than 150 years to deliver vaccines, medications and animal health products that save and improve the lives of millions around the world.
Our passion for medicine is evident in the breadth of our product line and the promise of our pipeline. Our worldwide product sales in 2013 were $44 billion. Our focus will remain on advancing and augmenting our pipeline, which we believe to be one of the most promising in our industry. Greater scientific discoveries – from our labs and through our collaborations with partners – will allow us to bring new life-changing therapies to patients and a strong financial performance to shareholders.
www.merck.com | Facebook | Twitter: @Merck
Scully, Scott, Murphy & Presser, P.C.
Celebrating its 41st year, Garden City-based Scully, Scott, Murphy & Presser, P.C. is one of Long Island’s largest and most prominent law firms exclusively dedicated to Intellectual Property. Comprised of highly skilled attorneys with highly technical backgrounds, SSMP confidently sits at the crossroads of cutting edge science, technology and law where it offers detailed, insightful opinions and secures, protects and enforces intellectual property for its clients. Intellectual Property Today has consistently ranked SSMP among the top 10% of all patent law firms in the United States, ranked #21 nationally, #2 in the New York Metro area and remains #1 on Long Island.
We continue to grow in the areas of biotechnology, chemistry, electronics, electrical engineering, computer science, internet, business methods, mechanical arts, nanotechnology, pharmaceuticals and material science. For more information, please visit our website or call 516-742-4343.
www.ssmp.com
SILVER
Acorda Therapeutics
Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological conditions.
Acorda markets three FDA-approved therapies including: AMPYRA®(dalfampridine) Extended Release Tablets, 10 mg, a treatment to improve walking in patients with MS; ZANAFLEX CAPSULES® (tizanidine hydrochloride) and Zanaflex tablets, a short-acting drug for the management of spasticity; and QUTENZA® (capsaicin) 8% Patch, for the management of neuropathic pain associated with postherpetic neuralgia. AMPYRA is marketed outside the United States as FAMPYRA® (prolonged-release fampridine tablets) by Biogen Idec under a licensing agreement from Acorda.
Acorda has one of the leading pipelines in the industry of novel neurological therapies. The Company is currently developing six clinical-stage therapies and one preclinical stage therapy that address a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic pain, and heart failure.
www.acorda.com | Twitter: @AcordaNews
Hoffmann & Baron LLP
Hoffmann & Baron, LLP is a full-service law firm specializing in all areas of intellectual property, both domestically and internationally. Intellectual property is among an organization’s most important assets. Hoffmann & Baron is an industry leader in patents, trademarks, copyright and trade secrets. We safeguard intellectual property assets through procurement, litigation, counseling, opinions and licensing.
Since 1984, Hoffmann & Baron, LLP has been working to protect ideas and to help transform those ideas into assets. What sets us apart is our personalized attention and ability to customize our services to fit the requirements of each client. We strive to provide timely and cost effective business-oriented counsel.
Hoffmann & Baron, LLP has offices in New York and New Jersey and serves clients around the globe in all scientific and engineering fields.
www.hbiplaw.com
Long Island High Technology Incubator
Stony Brook University offers 4 incubator facilities for start-up technology businesses. Our first and largest incubator, the Long Island High Technology Incubator, opened in 1992. Our businesses cover a broad range of technology areas including, but not limited to; biotechnology, biomedical, electronic components, communications, agriculture, aquaculture, software, wireless information technology, clean tech and alternative energy. We provide a fertile environment for technology development and commercialization. Our office/laboratory space is in close proximity to our research institutes that offer potential collaborators, student interns, potential employees, and many specialized research facilities. Through our economic development partners we also provide assistance with business plans, SBIR grant guidance, angel funding, or venture funding. Economic development resources in the region are also available through networking with our associated regional economic development partners.
Nixon Peabody
Nixon Peabody is a full-service law firm with over 600 attorneys in 16 offices throughout the U.S. and abroad. Our firm includes attorneys recognized in the life sciences industry, with an unrivaled understanding of the unique regulatory issues that impact life sciences companies in the United States. In addition, we are not only conversant in the complex federal and state laws that govern life sciences companies, but are also deeply attuned to the governments’ legislative priorities, regulatory agendas, and public policy debates.
Nixon Peabody sees 21st century law as a tool to help shape our clients’ futures. Our focus is on knowing what is important to our clients now and next so we can foresee obstacles and opportunities in their space and smooth the way. We ensure they are equipped with winning legal strategies as they navigate the exciting and challenging times we live in.
www.nixonpeabody.com | LinkedIn | Twitter:@NixonPeabodyLLP
Proskauer
Proskauer’s Patent Law group represents a cross-section of today’s most cutting-edge and successful companies in a wide range of industries, including academic centers and research institutions, biotechnology, medical devices, and pharmaceuticals. We assist clients in all phases of their patent needs, including litigation and dispute resolution, patent applications and contested patent office proceedings, and transactions and strategic counseling. Our work allows clients to maximize revenue, market position and shareholder value while retaining and growing their core assets.
Our team of patent lawyers, patent agents and technology specialists, the majority of whom have advanced degrees in science and engineering and/or practical industry experience, brings a strong combination of technical insight and industry savvy to all of the work we do. With our knowledge of both the courtroom and the boardroom, we add value at every stage of the patent development and protection process.
We have been widely commended by Chambers USA, which called us a “force to be reckoned with” in the patent area, and recognized by Corporate Counsel magazine as a “Go-To Law Firm for Leading Technology Companies,” in large part due to our patent work.
www.proskauer.com | Twitter: @proskauer
